Literature DB >> 10069359

The cephalosporins.

W F Marshall1, J E Blair.   

Abstract

The cephalosporins are a large group of related beta-lactam antimicrobial agents. Favorable attributes of the cephalosporins include low rates of toxicity, relatively broad spectrum of activity, and ease of administration. Various cephalosporins are effective for treatment of many conditions, including pneumonia, skin and soft tissue infections, bacteremia, and meningitis. Differences among the numerous cephalosporin antimicrobial agents are sometimes subtle; however, an understanding of these differences is essential for optimal use of these agents. As a result of widespread use of cephalosporins, bacterial resistance to these drugs is increasingly common. New, fourth-generation agents (such as cefepime) offer an alternative for the treatment of infections caused by some drug-resistant microorganisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069359     DOI: 10.4065/74.2.187

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  22 in total

1.  A complete library of amino acid alterations at N304 in Streptomyces clavuligerus deacetoxycephalosporin C synthase elucidates the basis for enhanced penicillin analogue conversion.

Authors:  Hong Soon Chin; Kian Sim Goo; T S Sim
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

2.  Effect of Maternal Obesity on Maternal-Fetal Transfer of Preoperative Cefazolin at Cesarean Section.

Authors:  Stephanie McKenney Groff; Wareef Fallatah; Samuel Yang; Jamie Murphy; Christopher Crutchfield; Mark Marzinke; Joanne Kurtzberg; Carlton K K Lee; Irina Burd; Azadeh Farzin
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

3.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

4.  Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysis.

Authors:  Angela S Loo; Michael Neely; Evan J Anderson; Cybele Ghossein; Milena M McLaughlin; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

Review 5.  Prevention and management of infection in children with sickle cell anaemia.

Authors:  W Y Wong
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.

Authors:  Lavanya Bathini; Racquel Jandoc; Paul Kuwornu; Eric McArthur; Matthew A Weir; Manish M Sood; Marisa Battistella; Flory T Muanda; Aiden Liu; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-10       Impact factor: 8.237

Review 8.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

Review 10.  Directed evolution and rational approaches to improving Streptomyces clavuligerus deacetoxycephalosporin C synthase for cephalosporin production.

Authors:  Kian-Sim Goo; Chun-Song Chua; Tiow-Suan Sim
Journal:  J Ind Microbiol Biotechnol       Date:  2009-03-07       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.